Experienced in Angiosarcoma

Fredrik Warnberg

Goeteborg, O, SE 
Experienced in Angiosarcoma
Goeteborg, O, SE 
OverviewLocationsClinical Research

Overview

Fredrik Warnberg practices in Goeteborg, Sweden. Mr. Warnberg is rated as an Experienced expert by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Breast Cancer, Pigmented Purpuric Dermatosis, Angiosarcoma, Melanoma, and Mastectomy.

His clinical research consists of co-authoring 113 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Angiosarcoma.

Gender
Male

Locations

Goeteborg, O, Sweden
Other Locations
Uppsala, C 75185, Sweden
Vaesteras, U, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Survival and Axillary Recurrence Following Sentinel Node-positive Breast Cancer Without Completion Axillary Lymph Node Dissection - a Randomized Study of Patients With Macrometastases in the Sentinel Node
Survival and Axillary Recurrence Following Sentinel Node-positive Breast Cancer Without Completion Axillary Lymph Node Dissection - a Randomized Study of Patients With Macrometastases in the Sentinel Node
Enrollment Status: Active_not_recruiting
Publish Date: March 04, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
Survival and Axillary Relapse in Breast Cancer Patients With Sentinel Node Micrometastases Who Have Not Undergone Completion Axillary Clearance - a National Cohort Study
Survival and Axillary Relapse in Breast Cancer Patients With Sentinel Node Micrometastases Who Have Not Undergone Completion Axillary Clearance - a National Cohort Study
Enrollment Status: Completed
Publish Date: March 10, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
View 1 Less Clinical Trial

113 Total Publications

Corrigendum to Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models.
Corrigendum to Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models.
Journal: The Journal of clinical investigation
Published: August 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Warnberg's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile